CryoCath

From WikiCover

Jump to: navigation, search

CryoCath is a medical technology company that develops cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

On June 28, 2007, CryoCath sold its surgical portfolio to ATS Medical.

On August 30, 2007, CryoCath announced the addition of Jesse Penn to the board of directors.

Website: http://www.cryocath.com/